Marta Perachino, Research fellow at Vall d’Hebron Institute of Oncology, shared a post on X:
“For those ESMOBreast24 check out our systematic review and metanalysis of ADCs vs TPC for mBC exploring more frequent AEs, discontinuation rate and impact on QoL.”
Source: Marta Perachino/X